Beijing Mabworks Biotech Co., Ltd.

This study is testing whether the drug MIL62 can safely prevent relapses in adults with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the nerves. Researchers will measure how long it takes for participants to have their first new attack wh…

This study is testing whether a new antibody drug called MIL62 can help control the symptoms and disease activity of systemic lupus erythematosus (SLE). The trial will compare MIL62 against a placebo in 120 adults with active lupus over 76 weeks. Researchers will measure whether …